| abstract |
A variant of a homodimerizing chemokine, such as human CCL2, having a single amino acid substitution that alters the hydrogen bonding pattern at the dimerization interface and acting as an absolute monomer, It can antagonize natural chemokines and has anti-inflammatory effects in vivo. These mutants can be used as active ingredients in pharmaceutical compositions for treating inflammation, autoimmune diseases, or infectious diseases. |